Acta Psychiatrica Scandinavica · 1981 · 46 citations · 14 references
PharmacyPharmacotherapyPsychiatryPsychiatric AssessmentPsychiatric PharmacotherapyPsychopharmacologyAntipsychotic PharmacologyAntipsychotic PharmacotherapyAntipsychotic TherapySchizophrenia PharmacotherapySchizophrenia Spectrum DisordersAcute Schizophrenia TreatmentAntipsychotic ActionAntipsychotic EfficacyAntipsychotic Medication UseOptimal Dose SelectionPropranolol TherapyPsychiatric Rating Scales
Similar improvement followed when propranolol and chlorpromazine were randomly used as the first drug after admission. Forty-six patients with florid symptoms of schizophrenia were assigned at random to have either racemic propranolol (24) or chlorpromazine (22). Each individual's drug was adjusted to an optimal dose, and the progress of the groups was followed for 12 weeks. Thirty-five patients remained in the study for 6 weeks, and 27 for 12 weeks. By weeks 6 and 12 the total schizophrenia scores on a modified Brief Psychiatric Rating Scale had improved significantly when the results from both groups were combined. The numbers leaving the study, and the amount and rate of improvement, were similar for both groups, but with a possible advantage to chlorpromazine. Side-effects, which usually were mild, were commoner in the chlorpromazine group.
14
The Brief Psychiatric Rating Scale
John E. Overall, Donald R. Gorham · Psychological Reports · 1962 · 10.9K citations
Measurement and classification of psychiatric symptoms
David Goldberg · Journal of Psychosomatic Research · 1975 · 2.2K citations
Diagnosis and Drug Treatment of Psychiatric Disorders
Frank J. Ayd · JAMA · 1969 · 306 citations
Propranolol in the Control of Schizophrenic Symptoms
Neil J. Yorkston, S. A. Zaki, Mazhar Malik et al. · BMJ · 1974 · 160 citations · Full text
Medicine, Pharmacology, Psychiatry +14
PROPRANOLOL AS AN ADJUNCT TO THE TREATMENT OF SCHIZOPHRENIA
NeilJ. Yorkston, S. A. Zaki, DavidR. Pitcher et al. · The Lancet · 1977 · 130 citations